UPDATE : Thursday, December 12, 2019
상단여백
Yuhan to start phase-3 trial on lung cancer drug Lazertinib by Jeong Sae-im 2019-12-12 15:04
Aprogen, 1st Korean biotech firm to win unicorn status by Jeong Sae-im 2019-12-11 13:10
Samsung execs get jail term for destroying evidence by Jeong Sae-im 2019-12-10 11:43
SK Biopharm set to ensure superiority in antiepileptic drug by Jeong Sae-im 2019-12-04 16:18
Samyang Biopharm’s US subsidiary to work on new immunotherapy by Jeong Sae-im 2019-12-03 15:37
라인
Alteogen inks licensing-out deal for SC injection formulation technology by Jeong Sae-im 2019-12-02 15:25
Daewoong challenges gastric acid blocker K-Cab with Fexuprazan by Jeong Sae-im 2019-11-29 15:23
New Parkinson’s drug Ongentys lands on Korea by Jeong Sae-im 2019-11-28 14:52
Kolon Life Science’s research head arrested for false Invossa data by Jeong Sae-im 2019-11-28 11:18
SK Chemicals wins FDA nod for patch-type Alzheimer’s drug by Jeong Sae-im 2019-11-27 18:24
라인
Roche Diagnostics challenges IBM Watson with differentiated strategy in tailor-made treatment market by Jeong Sae-im 2019-11-21 15:48
Oncologists vow to fight cancer through precision medicine by Jeong Sae-im 2019-11-21 14:28
Vivozon’s acquisition of Lumimicro may aim at backdoor listing by Jeong Sae-im 2019-11-20 14:44
PharmAbcine registers 1st patient for phase-2 trial on olinvacimab by Jeong Sae-im 2019-11-19 17:18
‘New law needed to curb rising chronic kidney disease’ by Jeong Sae-im 2019-11-19 11:45
라인
‘Udenafil improved exercise in single ventricle heart disease’ by Jeong Sae-im 2019-11-18 14:48
Prosecutors raid drugmakers, distributors for suspected bid-rigging by Jeong Sae-im 2019-11-14 15:27
How can Korean drugmakers enter Europe successfully? by Jeong Sae-im 2019-11-13 15:22
Samsung Bioepis expects ₩1 trillion biosimilar sales this year by Jeong Sae-im 2019-11-13 15:21
[News Focus] ‘FDA could allow resumption of Invossa trial’ by Jeong Sae-im 2019-11-12 15:48
여백
여백
여백
Back to Top